Nanomedicine and Nanoscale Delivery (Focus Group - NND)
Surgical Site Infections (SSIs) pose a significant healthcare challenge, further exacerbated by antimicrobial resistance (AMR) and the increasing prevalence of chronic wounds. In the UK, SSIs affect 3–4% of surgical patients, contributing to a 5% mortality rate, while in the US, chronic wounds impact over 6 million individuals, with associated healthcare costs exceeding $25 billion annually. Conventional wound dressings often fall short of promoting healing and preventing infection, highlighting the need for advanced therapeutic strategies.
Shabana Falak, MTech
Research Scholar
Indian Institue of Technology Bombay
Mumbai, Maharashtra, India